Search results
Trials to watch: Phase III BCG naïve non-muscle invasive bladder cancer
Clinical Trials Arena via Yahoo Finance· 5 days agoGiven... in patients with NMIBC. This includes AstraZeneca’s Imfinzi (NCT03528694), Pfizer’s...
Gateway - Quartz
Quartz· 7 days agoPharma giant AstraZeneca aims to increase its revenue by a whopping 75% in 2030, up from the $45.8 billion it generated in 2023 — just as it pulls its COVID-19 vaccines off ...
Texas Biomed expanding animal research complex with $20 million building
San Antonio Express-News· 5 days agoThe 18,440-square-foot building will house Texas Biomed’s Animal Health Center, the next phase of...
7 Dividend Stocks to Buy Now: June 2024
InvestorPlace· 2 days agoThese dividend stocks to buy now will reward investors with income now and growth as the market breadth expands.
Chutes & Ladders—Third Rock's cardiometabolic biotech unveils C-suite
FierceBiotech· 4 days agoPlease send the good word—or the bad—from your shop to Gabrielle Masson and it will be featured here...